| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |